Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia
NCT00138697Phase 3Completed
- Sponsor
- Prothya Biosolutions
- Start
- May 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Nanogam in hypogammaglobulinemia, sponsored by Prothya Biosolutions. Started May 2001; status: completed.
02
Drugs
Nanogam
03
Conditions
hypogammaglobulinemia
Beyond the preview
Go deeper on NCT00138697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138697.